Suppr超能文献

相似文献

1
Functional and structural insights into RAS effector proteins.
Mol Cell. 2024 Aug 8;84(15):2807-2821. doi: 10.1016/j.molcel.2024.06.027. Epub 2024 Jul 17.
3
Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association.
J Biol Chem. 2022 Dec;298(12):102661. doi: 10.1016/j.jbc.2022.102661. Epub 2022 Nov 9.
6
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
7
Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ.
J Mol Biol. 2021 Apr 16;433(8):166838. doi: 10.1016/j.jmb.2021.166838. Epub 2021 Feb 1.
8
Evaluating the Activity of Ras/Rap GTPases in Dictyostelium.
Methods Mol Biol. 2024;2814:163-176. doi: 10.1007/978-1-0716-3894-1_12.
9
Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket.
Cell. 2024 Oct 31;187(22):6379-6392.e17. doi: 10.1016/j.cell.2024.08.017. Epub 2024 Sep 9.
10
Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.
Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD013302. doi: 10.1002/14651858.CD013302.pub2.

引用本文的文献

2
Literature review of advances and challenges in mutant non-small cell lung cancer.
Transl Lung Cancer Res. 2025 Jul 31;14(7):2799-2820. doi: 10.21037/tlcr-2025-164. Epub 2025 Jul 15.
3
Structural-functional characterization of the MIRO1-TRAK1 complex.
Nat Commun. 2025 Jul 4;16(1):6173. doi: 10.1038/s41467-025-61174-6.
4
Cholangiocarcinoma Targeted Therapies: Mechanisms of Action and Resistance.
Am J Pathol. 2025 Mar;195(3):437-452. doi: 10.1016/j.ajpath.2024.11.005. Epub 2024 Dec 19.
5
Experimental variables determine the outcome of RAS-RAS interactions.
J Biol Chem. 2024 Nov;300(11):107859. doi: 10.1016/j.jbc.2024.107859. Epub 2024 Oct 5.
6
Ras signaling mechanisms: New insights from single-molecule biophysics.
Biophys J. 2024 Oct 1;123(19):3277-3280. doi: 10.1016/j.bpj.2024.08.025. Epub 2024 Aug 31.

本文引用的文献

1
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
Annu Rev Cancer Biol. 2024 Jun;8:97-113. doi: 10.1146/annurev-cancerbio-062822-030450. Epub 2023 Dec 5.
2
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.
Nature. 2024 May;629(8013):919-926. doi: 10.1038/s41586-024-07205-6. Epub 2024 Apr 8.
3
Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development.
Int J Mol Sci. 2024 Feb 22;25(5):2572. doi: 10.3390/ijms25052572.
4
The energetic and allosteric landscape for KRAS inhibition.
Nature. 2024 Feb;626(7999):643-652. doi: 10.1038/s41586-023-06954-0. Epub 2023 Dec 18.
5
Novel therapeutic perspectives in Noonan syndrome and RASopathies.
Eur J Pediatr. 2024 Mar;183(3):1011-1019. doi: 10.1007/s00431-023-05263-y. Epub 2023 Oct 21.
6
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS.
Science. 2023 Aug 18;381(6659):794-799. doi: 10.1126/science.adg9652. Epub 2023 Aug 17.
8
Defining bone fide effectors of RAS GTPases.
Bioessays. 2023 Sep;45(9):e2300088. doi: 10.1002/bies.202300088. Epub 2023 Jul 4.
9
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth.
Nature. 2023 Jul;619(7968):160-166. doi: 10.1038/s41586-023-06123-3. Epub 2023 May 31.
10
Structure-based prediction of Ras-effector binding affinities and design of "branchegetic" interface mutations.
Structure. 2023 Jul 6;31(7):870-883.e5. doi: 10.1016/j.str.2023.04.007. Epub 2023 May 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验